170 related articles for article (PubMed ID: 29715369)
1. Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial.
Asbell P; Vingrys AJ; Tan J; Ogundele A; Downie LE; Jerkins G; Shettle L
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2275-2280. PubMed ID: 29715369
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency.
Baudouin C; Galarreta DJ; Mrukwa-Kominek E; Böhringer D; Maurino V; Guillon M; Rossi GC; Van der Meulen IJ; Ogundele A; Labetoulle M
Eur J Ophthalmol; 2017 Mar; 27(2):122-128. PubMed ID: 27791253
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye.
Labetoulle M; Messmer EM; Pisella PJ; Ogundele A; Baudouin C
Br J Ophthalmol; 2017 Apr; 101(4):487-492. PubMed ID: 27422973
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
[TBL] [Abstract][Full Text] [Related]
5. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
Essa L; Laughton D; Wolffsohn JS
Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
[TBL] [Abstract][Full Text] [Related]
6. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
[TBL] [Abstract][Full Text] [Related]
8. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
Ousler GW; Michaelson C; Christensen MT
Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose.
Cohen S; Martin A; Sall K
Clin Ophthalmol; 2014; 8():157-64. PubMed ID: 24403819
[TBL] [Abstract][Full Text] [Related]
13. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models.
Ahn S; Eom Y; Kang B; Park J; Lee HK; Kim HM; Song JS
Curr Eye Res; 2018 May; 43(5):580-587. PubMed ID: 29419317
[TBL] [Abstract][Full Text] [Related]
14. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study.
Bickle K; Miller JR; Tauber J; Awisi-Gyau D
Ophthalmol Ther; 2024 Feb; 13(2):481-494. PubMed ID: 38079084
[TBL] [Abstract][Full Text] [Related]
15. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients.
Rolando M; Autori S; Badino F; Barabino S
J Ocul Pharmacol Ther; 2009 Jun; 25(3):271-8. PubMed ID: 19366323
[TBL] [Abstract][Full Text] [Related]
16. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
17. Lubricant with gelling agent in treating dry eye in adult Chinese patients.
Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L
Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726
[TBL] [Abstract][Full Text] [Related]
18. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
Cömez AT; Tufan HA; Kocabıyık O; Gencer B
Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
[TBL] [Abstract][Full Text] [Related]
19. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
20. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
